WallStreetZenWallStreetZen

NYSE: EBS
Emergent Biosolutions Inc Stock Ownership - Who owns Emergent Biosolutions?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Emergent Biosolutions Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Donald W. DegolyerDirector2026-10-0717,800$7.09
$126.20kSell
Paul Anthony WilliamsSVP2026-10-013,000$6.53
$19.59kSell
Paul Anthony WilliamsSVP Products Business2026-07-013,000$8.40
$25.20kSell
William HartzelSVP Bioservices2026-06-081,741$8.00
$13.93kSell
Paul Anthony WilliamsSVP Products Business2026-06-08694$8.00
$5.55kSell
Coleen GlessnerEVP Quality Ethics and CPL2026-06-082,018$8.00
$16.14kSell
Richard S. LindahlEVP Chief Financial Officer2026-06-083,964$8.00
$31.71kSell
Sujata Tyagi DayalDirector2026-05-0112,781$8.36
$106.85kSell
Sujata Tyagi DayalDirector2026-05-01980$8.94
$8.76kSell
Kathryn C. ZoonDirector2026-05-0116,145$8.36
$134.97kSell

1 of 5

EBS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EBS insiders and whales buy or sell their stock.

EBS Shareholders

What type of owners hold Emergent Biosolutions Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fuad Elhibri50.05%25,733,310$155.94MInsider
Intervac LLC8.45%4,344,250$26.33MInsider
Biopharm LLC4.41%2,265,043$13.73MInsider
Robert Calvin Myers3.76%1,934,849$11.73MInsider
Biovac LLC3.11%1,599,155$9.69MInsider
Apax Europe IV GP Co Ltd2.83%1,455,361$8.82MInsider
Biologika LLC2.72%1,399,764$8.48MInsider
Mauro Gibellini2.67%1,375,084$8.33MInsider
Robert Kramer2.65%1,363,102$8.26MInsider
Michigan Biologic Products Inc2.47%1,269,390$7.69MInsider

1 of 3

EBS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EBS0.09%99.04%Net SellingNet Selling
ACB0.01%0.00%
CGC0.01%25.96%Net SellingNet Selling
BIOA0.08%21.56%Net Selling
LFCR0.07%68.29%Net Selling
View Top Pharmaceutical Stocks

Emergent Biosolutions Stock Ownership FAQ

Who owns Emergent Biosolutions?

Emergent Biosolutions (NYSE: EBS) is owned by 0.09% institutional shareholders, 99.04% Emergent Biosolutions insiders, and 0.88% retail investors. Fuad Elhibri is the largest individual Emergent Biosolutions shareholder, owning 25.73M shares representing 50.05% of the company. Fuad Elhibri's Emergent Biosolutions shares are currently valued at $155.94M.

If you're new to stock investing, here's how to buy Emergent Biosolutions stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.